Balance Sheet Novo Nordisk A/S

Stocks

NOVO B

DK0062498333

Pharmaceuticals

Market Closed - Nasdaq Copenhagen Other stock markets 08:50:00 20/07/2026 pm IST			5-day change	1st Jan Change
328.00 ^DKK	-0.58%		+1.11%	+0.85%

20/07	Aspen Pharmacare wins Canada approval for generic Ozempic after Novo patent expiry	RE
20/07	Aspen Pharmacare wins Canada approval for generic Ozempic injection	RE

cbe48f7.RkH3Y8dFVWkWZCWQS3-rjl71NsFUrKEqw2vl7pXprjQ.dyeQMa4sMyphEUrpDyD4_mulA4kQxeVilgGTqNK24GEPBs4Jrho5JyISQg

Published financial data: NOVO NORDISK A/S

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	14TCr	18TCr	23TCr	29TCr	31TCr
Total Revenues	14TCr	18TCr	23TCr	29TCr	31TCr
Cost of Goods Sold, Total	2.37TCr	2.84TCr	3.58TCr	4.36TCr	5.44TCr
Gross Profit	12TCr	15TCr	20TCr	25TCr	25TCr
Selling General & Admin Expenses, Total	4.11TCr	5.07TCr	6.16TCr	6.74TCr	6.79TCr
R&D Expenses	1.72TCr	2.33TCr	3.1TCr	4.01TCr	4.62TCr
Other Operating Expenses	-46Cr	-108.5Cr	-12Cr	-48Cr	4.5Cr
Other Operating Expenses, Total	5.78TCr	7.29TCr	9.25TCr	11TCr	11TCr
Operating Income	5.93TCr	7.56TCr	10TCr	14TCr	14TCr
Interest Expense, Total	-29Cr	-38Cr	-54Cr	-164Cr	-420.7Cr
Interest And Investment Income	23Cr	24Cr	106.9Cr	183.8Cr	126.9Cr
Net Interest Expenses	-5.8Cr	-14Cr	53Cr	20Cr	-293.8Cr
Income (Loss) On Equity Invest.	-2.4Cr	-19Cr	8.1Cr	-1.7Cr	-1.7Cr
Currency Exchange Gains (Loss)	34Cr	-465.1Cr	165.2Cr	-102.3Cr	600.7Cr
Other Non Operating Income (Expenses)	-12Cr	-18Cr	-20Cr	-29Cr	-24Cr
EBT, Excl. Unusual Items	5.95TCr	7.05TCr	11TCr	14TCr	14TCr
Restructuring Charges	-	-	-	-	-936.6Cr
Merger & Related Restructuring Charges	-12Cr	-5.1Cr	-	-98Cr	-
Gain (Loss) On Sale Of Investments	30Cr	-59Cr	3.7Cr	-1.7Cr	7.1Cr
Asset Writedown	-57Cr	-76Cr	-141.4Cr	-1.06TCr	-359.4Cr
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	5.91TCr	6.91TCr	10TCr	13TCr	13TCr
Income Tax Expense	1.13TCr	1.35TCr	2.1TCr	2.62TCr	2.81TCr
Earnings From Continuing Operations	4.78TCr	5.55TCr	8.37TCr	10TCr	10TCr
Net Income to Company	4.78TCr	5.55TCr	8.37TCr	10TCr	10TCr
Net Income - (IS)	4.78TCr	5.55TCr	8.37TCr	10TCr	10TCr
Net Income to Common Incl Extra Items	4.78TCr	5.55TCr	8.37TCr	10TCr	10TCr
Net Income to Common Excl. Extra Items	4.78TCr	5.55TCr	8.37TCr	10TCr	10TCr
Per Share Items
Net EPS - Basic	10.4	12.26	18.67	22.67	23.06
Basic EPS - Continuing Operations	10.4	12.26	18.67	22.67	23.06
Basic Weighted Average Shares Outstanding	459.32Cr	453.06Cr	448.28Cr	445.39Cr	444.3Cr
Net EPS - Diluted	10.37	12.22	18.62	22.63	23.03
Diluted EPS - Continuing Operations	10.37	12.22	18.62	22.63	23.03
Diluted Weighted Average Shares Outstanding	460.62Cr	454.46Cr	449.48Cr	446.3Cr	444.77Cr
Normalized Basic EPS	8.09	9.72	14.79	19.47	20.18
Normalized Diluted EPS	8.07	9.69	14.75	19.43	20.15
Dividend Per Share	5.2	6.2	9.4	11.4	11.7
Payout Ratio	45.06	45.57	37.96	43.71	50.53
American Depositary Receipts Ratio (ADR)	0	0	0	0	0
Supplemental Items
EBITDA	6.36TCr	8.09TCr	11TCr	15TCr	15TCr
EBITA	6.02TCr	7.7TCr	11TCr	14TCr	15TCr
EBIT	5.93TCr	7.56TCr	10TCr	14TCr	14TCr
EBITDAR	6.49TCr	8.24TCr	11TCr	-	-
Effective Tax Rate - (Ratio)	19.17	19.6	20.05	20.6	21.53
Total Current Taxes	1.33TCr	1.82TCr	2.5TCr	3.23TCr	2.9TCr
Total Deferred Taxes	-194.5Cr	-463.1Cr	-401.1Cr	-605.1Cr	-88Cr
Normalized Net Income	3.72TCr	4.4TCr	6.63TCr	8.67TCr	8.96TCr
Interest on Long-Term Debt	-	-	-	-	-
Non-Cash Pension Expense	14Cr	18Cr	13Cr	16Cr	13Cr
Supplemental Operating Expense Items
Selling and Marketing Expenses	3.7TCr	4.62TCr	5.67TCr	6.21TCr	6.27TCr
General and Administrative Expenses	405Cr	446.7Cr	485.5Cr	527.6Cr	516Cr
Research And Development Expense From Footnotes	1.78TCr	2.4TCr	3.24TCr	4.81TCr	5.2TCr
Net Rental Expense, Total	130.3Cr	149.1Cr	183.2Cr	-	-
Imputed Operating Lease Interest Expense	16Cr	17Cr	30Cr	-	-
Imputed Operating Lease Depreciation	114.02Cr	131.9Cr	153.11Cr	-	-
Stock-Based Comp., Other (Total)	104Cr	153.9Cr	214.9Cr	228.9Cr	143.5Cr
Total Stock-Based Compensation	104Cr	153.9Cr	214.9Cr	228.9Cr	143.5Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	1.07TCr	1.27TCr	1.44TCr	1.57TCr	2.65TCr
Short Term Investments	676.5Cr	1.09TCr	1.58TCr	1.07TCr	50Cr
Total Cash And Short Term Investments	1.75TCr	2.36TCr	3.02TCr	2.63TCr	2.7TCr
Accounts Receivable, Total	4.06TCr	5.06TCr	6.48TCr	7.19TCr	7.09TCr
Other Receivables	615.6Cr	694.5Cr	1.05TCr	1.55TCr	1.83TCr
Total Receivables	4.68TCr	5.75TCr	7.53TCr	8.74TCr	8.92TCr
Inventory	1.96TCr	2.44TCr	3.18TCr	4.08TCr	4.96TCr
Other Current Assets, Total	169Cr	272.7Cr	234.4Cr	632.6Cr	668.2Cr
Total Current Assets	8.56TCr	11TCr	14TCr	16TCr	17TCr
Gross Property Plant And Equipment	9.59TCr	11TCr	14TCr	21TCr	27TCr
Accumulated Depreciation	-4.05TCr	-4.48TCr	-4.76TCr	-5.24TCr	-5.89TCr
Net Property Plant And Equipment	5.54TCr	6.67TCr	9.1TCr	16TCr	21TCr
Long-term Investments	144.1Cr	134.3Cr	166.3Cr	267.7Cr	250.7Cr
Goodwill	434.6Cr	509.2Cr	446.4Cr	2.01TCr	1.98TCr
Other Intangibles, Total	3.88TCr	4.63TCr	5.59TCr	9.1TCr	11TCr
Deferred Tax Assets Long-Term	867.2Cr	1.34TCr	2.04TCr	2.46TCr	2.36TCr
Other Long-Term Assets, Total	27Cr	21Cr	143Cr	401.6Cr	586.4Cr
Total Assets	19TCr	24TCr	31TCr	47TCr	54TCr
Liabilities
Accounts Payable, Total	887Cr	1.56TCr	2.56TCr	2.88TCr	1.98TCr
Accrued Expenses, Total	5.06TCr	6.92TCr	10TCr	12TCr	92Cr
Short-term Borrowings	1.29TCr	48Cr	46Cr	579.2Cr	93Cr
Current Portion of Long-Term Debt	-	-	484.8Cr	598.3Cr	975.3Cr
Current Portion of Leases	82Cr	99Cr	117.4Cr	133.8Cr	133.6Cr
Current Income Taxes Payable	365.8Cr	709.1Cr	711.6Cr	971.6Cr	841.6Cr
Other Current Liabilities	2.27TCr	2.76TCr	3.04TCr	4.69TCr	17TCr
Total Current Liabilities	9.95TCr	12TCr	17TCr	22TCr	22TCr
Long-Term Debt	965.4Cr	2.08TCr	1.6TCr	8.42TCr	11TCr
Long-Term Leases	330.7Cr	354.3Cr	455.2Cr	542.8Cr	723.6Cr
Pension & Other Post Retirement Benefits	128Cr	76Cr	74Cr	90Cr	86Cr
Deferred Tax Liability Non Current	527.1Cr	706.1Cr	1.02TCr	542.6Cr	661.1Cr
Other Non Current Liabilities	473.4Cr	469Cr	683.8Cr	877.8Cr	678.1Cr
Total Liabilities	12TCr	16TCr	21TCr	32TCr	35TCr
Common Stock, Total	46Cr	46Cr	45Cr	45Cr	45Cr
Retained Earnings	7.2TCr	8.06TCr	10TCr	14TCr	20TCr
Treasury Stock	-60L	-60L	-50L	-20L	-20L
Comprehensive Income and Other	-171.4Cr	244.9Cr	127.6Cr	-140.6Cr	-169.5Cr
Total Common Equity	7.07TCr	8.35TCr	11TCr	14TCr	19TCr
Total Equity	7.07TCr	8.35TCr	11TCr	14TCr	19TCr
Total Liabilities And Equity	19TCr	24TCr	31TCr	47TCr	54TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	455.78Cr	450.07Cr	445.83Cr	444.1Cr	444.4Cr
ECS Total Common Shares Outstanding	455.78Cr	450.07Cr	445.83Cr	444.1Cr	444.4Cr
Book Value / Share	15.52	18.55	23.9	32.31	43.66
Tangible Book Value	2.76TCr	3.21TCr	4.62TCr	3.24TCr	6.4TCr
Tangible Book Value Per Share	6.05	7.13	10.35	7.29	14.4
Total Debt	2.66TCr	2.58TCr	2.7TCr	10TCr	13TCr
Net Debt	916Cr	221Cr	-322.4Cr	7.65TCr	10TCr
Debt Equivalent of Unfunded Proj. Benefit Obligation	-	-	-	-	-
Debt Equivalent Oper. Leases	1.04TCr	1.19TCr	1.47TCr	-	-
Equity Method Investments, Total	52Cr	33Cr	41Cr	40Cr	37Cr
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	431Cr	639.2Cr	950Cr	1.34TCr	1.74TCr
Inventories - Work In Process, Total	1.23TCr	1.37TCr	1.76TCr	2.23TCr	2.59TCr
Inventories - Finished Goods, Total	528.2Cr	603.8Cr	722.4Cr	887.3Cr	1.2TCr
Land - (BS)	4.11TCr	4.34TCr	4.9TCr	6.21TCr	6.56TCr
Machinery, Total	4.37TCr	4.57TCr	4.99TCr	7.34TCr	7.11TCr
Full Time Employees	47.79T	54.39T	63.37T	76.3T	68.79T
Part Time Employees	686	792	949	1.05T	711
Accumulated Allowance for Doubtful Accounts (Supple)	143Cr	152Cr	179.4Cr	212.7Cr	198.7Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	4.78TCr	5.55TCr	8.37TCr	10TCr	10TCr
Depreciation & Amortization - CF	424.5Cr	495.4Cr	545.5Cr	603.3Cr	813.7Cr
Amortization of Goodwill and Intangible Assets - (CF)	87Cr	140.4Cr	162.1Cr	225.7Cr	621.1Cr
Depreciation & Amortization, Total	511.1Cr	635.8Cr	707.6Cr	829Cr	1.43TCr
Amortization of Deferred Charges, Total - (CF)	20Cr	20Cr	21Cr	26Cr	32Cr
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-34Cr	12Cr	-	-507.9Cr	416.1Cr
Asset Writedown & Restructuring Costs	71Cr	81Cr	212.4Cr	1.06TCr	731.6Cr
(Income) Loss On Equity Investments - (CF)	2.4Cr	19Cr	-	1.7Cr	1.7Cr
Stock-Based Compensation (CF)	104Cr	153.9Cr	-	228.9Cr	143.5Cr
Other Operating Activities, Total	915Cr	1.95TCr	2.81TCr	1.56TCr	-1.47TCr
Change In Accounts Receivable	-1.29TCr	-991.7Cr	-1.42TCr	-717.9Cr	109.3Cr
Change In Inventories	-108.5Cr	-476.7Cr	-742.3Cr	-903.8Cr	-877.4Cr
Change In Accounts Payable	315.3Cr	671.7Cr	1TCr	324Cr	261.8Cr
Change in Other Net Operating Assets	218.5Cr	263.1Cr	-63Cr	98Cr	880Cr
Cash from Operations	5.5TCr	7.89TCr	11TCr	12TCr	12TCr
Capital Expenditure	-633.5Cr	-1.21TCr	-2.58TCr	-4.72TCr	-6.01TCr
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	-1.83TCr	-707.5Cr	-	-8.22TCr	100.4Cr
Divestitures	-	-	-	-	-
Sale (Purchase) of Intangible assets	-105Cr	-260.7Cr	-1.31TCr	-414.5Cr	-3TCr
Investment in Marketable and Equity Securities, Total	-594.1Cr	-309Cr	-499.6Cr	457.7Cr	995.1Cr
Other Investing Activities, Total	40L	-	-	-	-
Cash from Investing	-3.16TCr	-2.49TCr	-4.39TCr	-13TCr	-7.92TCr
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	2.22TCr	1.12TCr	-	7.94TCr	10TCr
Total Debt Issued	2.22TCr	1.12TCr	-	7.94TCr	10TCr
Long-Term Debt Repaid, Total	-668.9Cr	-1.36TCr	-146.7Cr	-633.5Cr	-7.92TCr
Total Debt Repaid	-668.9Cr	-1.36TCr	-146.7Cr	-633.5Cr	-7.92TCr
Repurchase of Common Stock	-1.94TCr	-2.41TCr	-2.99TCr	-2.02TCr	-138.8Cr
Common Dividends Paid	-2.15TCr	-2.53TCr	-3.18TCr	-4.41TCr	-5.18TCr
Common & Preferred Stock Dividends Paid	-2.15TCr	-2.53TCr	-3.18TCr	-4.41TCr	-5.18TCr
Cash from Financing	-2.55TCr	-5.18TCr	-6.32TCr	873.5Cr	-2.84TCr
Foreign Exchange Rate Adjustments	59Cr	-24Cr	-12Cr	46Cr	-73Cr
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	-150.7Cr	193.4Cr	173.9Cr	126.3Cr	1.08TCr
Supplemental Items
Cash Interest Paid	26Cr	27Cr	49Cr	61Cr	341.9Cr
Cash Income Tax Paid (Refund)	1.44TCr	1.45TCr	2.59TCr	2.96TCr	3.2TCr
Levered Free Cash Flow	4.38TCr	5.75TCr	5.41TCr	6.2TCr	38Cr
Unlevered Free Cash Flow	4.4TCr	5.77TCr	5.44TCr	6.3TCr	300.62Cr
Change In Net Working Capital	-796Cr	-1.71TCr	-1.89TCr	-1.61TCr	1.09TCr
Net Debt Issued / Repaid	1.55TCr	-240.8Cr	-146.7Cr	7.31TCr	2.47TCr

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	21.85	21.69	23.39	22.41	17.43
Return on Total Capital	43.36	45.74	53.53	46.03	30.77
Return On Equity %	71.24	72	88.07	80.78	60.7
Return on Common Equity	71.24	72	88.07	80.78	60.7
Margin Analysis
Gross Profit Margin %	83.2	83.92	84.6	85	82.41
SG&A Margin	29.16	28.64	26.52	23.2	21.96
EBITDA Margin %	45.14	45.73	47.28	50.51	49.6
EBITA Margin %	42.76	43.53	45.47	48.94	47.51
EBIT Margin %	42.15	42.73	44.77	48.17	45.5
Income From Continuing Operations Margin %	33.92	31.38	36.03	34.78	33.14
Net Income Margin %	33.92	31.38	36.03	34.78	33.14
Net Avail. For Common Margin %	33.92	31.38	36.03	34.78	33.14
Normalized Net Income Margin	26.4	24.89	28.54	29.86	29
Levered Free Cash Flow Margin	31.13	32.49	23.29	21.35	0.12
Unlevered Free Cash Flow Margin	31.26	32.63	23.44	21.7	0.97
Asset Turnover
Asset Turnover	0.83	0.81	0.84	0.74	0.61
Fixed Assets Turnover	2.67	2.9	2.95	2.29	1.67
Receivables Turnover (Average Receivables)	4.12	3.88	4.03	4.25	4.33
Inventory Turnover (Average Inventory)	1.24	1.29	1.27	1.2	1.2
Short Term Liquidity
Current Ratio	0.86	0.89	0.82	0.74	0.8
Quick Ratio	0.65	0.67	0.62	0.52	0.54
Operating Cash Flow to Current Liabilities	0.55	0.65	0.64	0.56	0.55
Days Sales Outstanding (Average Receivables)	88.63	94.06	90.62	86.15	84.33
Days Outstanding Inventory (Average Inventory)	294.35	282.33	286.77	305.25	303.64
Average Days Payable Outstanding	107.59	134.38	174.07	189.45	106.63
Cash Conversion Cycle (Average Days)	275.38	242.01	203.32	201.96	281.34
Long Term Solvency
Total Debt/Equity	37.66	30.88	25.34	71.64	67.49
Total Debt / Total Capital	27.36	23.6	20.22	41.74	40.29
LT Debt/Equity	18.32	29.13	19.26	62.5	61.29
Long-Term Debt / Total Capital	13.31	22.25	15.37	36.41	36.6
Total Liabilities / Total Assets	63.63	65.4	66.12	69.2	64.26
EBIT / Interest Expense	205.33	200.05	191.86	85.29	33.42
EBITDA / Interest Expense	223.02	216.87	204.92	90.35	36.84
(EBITDA - Capex) / Interest Expense	201.1	184.74	157.3	61.59	22.54
Total Debt / EBITDA	0.41	0.31	0.24	0.69	0.85
Net Debt / EBITDA	0.14	0.03	-0.03	0.52	0.67
Total Debt / (EBITDA - Capex)	0.46	0.37	0.32	1.02	1.38
Net Debt / (EBITDA - Capex)	0.16	0.03	-0.04	0.76	1.1
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	10.91	25.68	31.26	25.03	6.43
Gross Profit, 1 Yr. Growth %	10.5	26.77	32.32	25.34	3.18
EBITDA, 1 Yr. Growth %	8.49	27.34	35.78	32.7	5.22
EBITA, 1 Yr. Growth %	8.75	27.93	37.2	33.69	4.02
EBIT, 1 Yr. Growth %	8.93	27.43	37.61	33.6	1.24
Earnings From Cont. Operations, 1 Yr. Growth %	13.33	16.27	50.71	20.68	1.43
Net Income, 1 Yr. Growth %	13.33	16.27	50.71	20.68	1.43
Normalized Net Income, 1 Yr. Growth %	10.82	18.46	50.62	29.96	4.11
Diluted EPS Before Extra, 1 Yr. Growth %	15.16	17.84	52.37	21.54	1.77
Accounts Receivable, 1 Yr. Growth %	46.55	24.4	28.11	11.08	-1.52
Inventory, 1 Yr. Growth %	5.85	24.3	30.44	28.41	21.48
Net Property, Plant and Equip., 1 Yr. Growth %	10.13	20.43	36.43	78.63	28.88
Total Assets, 1 Yr. Growth %	34.22	24.03	30.35	48.11	16.6
Tangible Book Value, 1 Yr. Growth %	-35.37	16.3	41.81	-29.81	95.91
Common Equity, 1 Yr. Growth %	11.72	18.01	27.64	34.65	35.24
Cash From Operations, 1 Yr. Growth %	5.87	43.43	38.06	11.07	-1.54
Capital Expenditures, 1 Yr. Growth %	8.76	91.73	112.46	82.76	27.51
Levered Free Cash Flow, 1 Yr. Growth %	157	31.17	-5.85	13.64	-99.38
Unlevered Free Cash Flow, 1 Yr. Growth %	154.42	31.17	-5.65	14.81	-95.12
Dividend Per Share, 1 Yr. Growth %	14.29	19.23	51.61	21.28	2.63
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	7.42	18.06	28.44	28.11	15.35
Gross Profit, 2 Yr. CAGR %	7.2	18.36	29.52	28.91	13.72
EBITDA, 2 Yr. CAGR %	6.24	17.55	31.23	34.46	17.66
EBITA, 2 Yr. CAGR %	6.61	18.1	32.36	35.67	17.4
EBIT, 2 Yr. CAGR %	6.33	18.2	32.52	36.01	15.89
Earnings From Cont. Operations, 2 Yr. CAGR %	10.73	14.79	32.37	34.86	10.64
Net Income, 2 Yr. CAGR %	10.73	14.79	32.37	34.86	10.64
Normalized Net Income, 2 Yr. CAGR %	10.52	14.95	33.67	40.33	15.91
Diluted EPS Before Extra, 2 Yr. CAGR %	12.52	16.49	34	36.08	11.21
Accounts Receivable, 2 Yr. CAGR %	27.73	35.02	26.24	19.29	4.59
Inventory, 2 Yr. CAGR %	5.46	14.7	27.33	29.42	24.9
Net Property, Plant and Equip., 2 Yr. CAGR %	4.65	15.16	28.18	56.11	51.36
Total Assets, 2 Yr. CAGR %	24.44	29.02	27.15	38.95	31.39
Tangible Book Value, 2 Yr. CAGR %	-27.01	-13.3	29.38	-0.23	17.75
Common Equity, 2 Yr. CAGR %	10.83	14.82	22.73	31.1	34.94
Cash From Operations, 2 Yr. CAGR %	8.43	23.23	40.72	23.83	4.58
Capital Expenditures, 2 Yr. CAGR %	-15.78	44.4	101.83	97.06	52.66
Levered Free Cash Flow, 2 Yr. CAGR %	27.93	84.1	11.02	3.83	-91.69
Unlevered Free Cash Flow, 2 Yr. CAGR %	27.86	83.17	11.14	4.47	-76.6
Dividend Per Share, 2 Yr. CAGR %	11.6	16.73	34.45	35.6	11.57
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	7.98	13.19	22.31	27.29	20.43
Gross Profit, 3 Yr. CAGR %	7.53	13.36	22.84	28.2	19.69
EBITDA, 3 Yr. CAGR %	7.49	12.85	23.31	32	23.63
EBITA, 3 Yr. CAGR %	8.41	13.29	24.13	33.1	23.89
EBIT, 3 Yr. CAGR %	7.89	12.95	24.32	33.18	22.97
Earnings From Cont. Operations, 3 Yr. CAGR %	7.33	12.54	25.7	28.35	22.65
Net Income, 3 Yr. CAGR %	7.33	12.54	25.7	28.35	22.65
Normalized Net Income, 3 Yr. CAGR %	7.82	13.1	25.76	32.71	26.74
Diluted EPS Before Extra, 3 Yr. CAGR %	9.19	14.27	27.4	29.71	23.52
Accounts Receivable, 3 Yr. CAGR %	21.28	26.61	32.67	20.97	11.91
Inventory, 3 Yr. CAGR %	6.3	11.4	19.73	27.69	26.72
Net Property, Plant and Equip., 3 Yr. CAGR %	9.74	9.67	21.86	43.18	46.21
Total Assets, 3 Yr. CAGR %	20.64	24.3	29.47	33.79	31.04
Tangible Book Value, 3 Yr. CAGR %	-16.1	-14.75	2.65	5.52	25.28
Common Equity, 3 Yr. CAGR %	10.92	13.17	18.94	26.58	32.46
Cash From Operations, 3 Yr. CAGR %	7.22	19.03	27.98	30.05	14.72
Capital Expenditures, 3 Yr. CAGR %	-13.05	10.79	64.24	95.26	70.44
Levered Free Cash Flow, 3 Yr. CAGR %	16.82	29	47.2	12.19	-81.29
Unlevered Free Cash Flow, 3 Yr. CAGR %	16.91	28.96	46.8	12.65	-62.66
Dividend Per Share, 3 Yr. CAGR %	8.47	14.09	27.36	29.91	23.58
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	4.72	9.64	15.74	18.94	19.48
Gross Profit, 5 Yr. CAGR %	4.37	9.56	15.84	19.35	19.16
EBITDA, 5 Yr. CAGR %	4.24	9.19	16.5	21.1	21.22
EBITA, 5 Yr. CAGR %	4.27	9.48	17.45	21.82	21.6
EBIT, 5 Yr. CAGR %	4.15	9.08	17.09	21.66	21.04
Earnings From Cont. Operations, 5 Yr. CAGR %	4.72	7.81	16.72	20.99	19.44
Net Income, 5 Yr. CAGR %	4.72	7.81	16.72	20.99	19.44
Normalized Net Income, 5 Yr. CAGR %	4.48	7.66	17.45	23.29	21.88
Diluted EPS Before Extra, 5 Yr. CAGR %	6.75	9.69	18.51	22.54	20.66
Accounts Receivable, 5 Yr. CAGR %	14.97	20.18	23.24	23.63	20.63
Inventory, 5 Yr. CAGR %	6.47	9.67	14.26	18.29	21.77
Net Property, Plant and Equip., 5 Yr. CAGR %	12.9	13.6	16.77	26.3	32.9
Total Assets, 5 Yr. CAGR %	14.8	18.71	23.21	29.97	30.23
Tangible Book Value, 5 Yr. CAGR %	-8.31	-7.16	-0.23	-8.95	8.44
Common Equity, 5 Yr. CAGR %	9.34	10.88	15.5	20.03	25.1
Cash From Operations, 5 Yr. CAGR %	2.63	13.89	19.54	20.93	18.05
Capital Expenditures, 5 Yr. CAGR %	-2.17	9.76	21.78	39.49	59.5
Levered Free Cash Flow, 5 Yr. CAGR %	8.96	21.89	14.5	18.27	-53.3
Unlevered Free Cash Flow, 5 Yr. CAGR %	9.02	21.93	14.6	18.54	-29.46
Dividend Per Share, 5 Yr. CAGR %	6.47	9.57	18.2	22.25	20.79